BioNTech SE

11/22/2021 | Press release | Distributed by Public on 11/22/2021 07:56

Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age - Form 6-K